Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer

Epidermal Growth Factor Receptor (EGFR) is overexpressed on a number of human cancers, and often is indicative of a poor outcome. Treatment of EGFR/HER2 overexpressing cancers includes monoclonal antibody therapy (cetuximab/trastuzumab) either alone or in conjunction with other standard cancer thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Doyle, Hester A., Gee, Renelle J., Masters, Tyler D., Gee, Christian R., Booth, Carmen J., Peterson-Roth, Elizabeth, Koski, Raymond A., Helfand, Stuart C., Price, Lauren, Bascombe, Deborah, Jackson, Dorothy, Ho, Rita, Post, Gerald R., Mamula, Mark J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379704/
https://www.ncbi.nlm.nih.gov/pubmed/34419682
http://dx.doi.org/10.1016/j.tranon.2021.101205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379704/
https://www.ncbi.nlm.nih.gov/pubmed/34419682
http://dx.doi.org/10.1016/j.tranon.2021.101205

Ejemplares similares